IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 219 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.65 and the average weighting 0.1%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MHR Fund Management | 11,997,103 | $84,459,605 | 11.88% |
| MPM BioImpact LLC | 2,950,118 | $20,768,831 | 4.18% |
| Perceptive Advisors | 14,036,410 | $98,816,326 | 2.86% |
| Velan Capital Investment Management LP | 240,000 | $1,689,600 | 1.57% |
| Parametrica Management Ltd | 96,500 | $679,360 | 1.31% |
| Boxer Capital, LLC | 3,705,133 | $26,084 | 1.21% |
| Soleus Capital Management, L.P. | 1,239,777 | $8,728,030 | 0.97% |
| Opaleye Management Inc. | 421,000 | $2,963,840 | 0.71% |
| 683 Capital Management, LLC | 1,400,000 | $9,856,000 | 0.71% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,758,759 | $12,381,665 | 0.70% |
| Avoro Capital Advisors LLC | 6,700,000 | $47,168,000 | 0.64% |
| Rhenman & Partners Asset Management AB | 850,000 | $5,984,000 | 0.63% |
| Long Focus Capital Management, LLC | 1,876,814 | $13,212,771 | 0.60% |
| Orbimed Advisors | 4,707,458 | $33,140,504 | 0.60% |
| Harvest Investment Services, LLC | 124,943 | $879,599 | 0.50% |
| Hood River Capital Management LLC | 1,975,551 | $13,908,000 | 0.41% |
| Aristotle Atlantic Partners, LLC | 1,218,025 | $8,574,896 | 0.32% |
| Vivo Capital, LLC | 655,057 | $4,611,601 | 0.32% |
| QVT Financial LP | 678,564 | $4,777,091 | 0.26% |
| PFM Health Sciences, LP | 946,305 | $6,661,987 | 0.26% |
External links
This page lists IOVANCE BIOTHERAPEUTICS INC's shareholders in Q2 2023. To view IOVANCE BIOTHERAPEUTICS INC's shareholder history, click here.